Last reviewed · How we verify
cream 0.1% methylprednisolone aceponate
cream 0.1% methylprednisolone aceponate is a Small molecule drug developed by National Medical Research Center for Children's Health, Russian Federation. It is currently FDA-approved.
At a glance
| Generic name | cream 0.1% methylprednisolone aceponate |
|---|---|
| Sponsor | National Medical Research Center for Children's Health, Russian Federation |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cream 0.1% methylprednisolone aceponate CI brief — competitive landscape report
- cream 0.1% methylprednisolone aceponate updates RSS · CI watch RSS
- National Medical Research Center for Children's Health, Russian Federation portfolio CI
Frequently asked questions about cream 0.1% methylprednisolone aceponate
What is cream 0.1% methylprednisolone aceponate?
cream 0.1% methylprednisolone aceponate is a Small molecule drug developed by National Medical Research Center for Children's Health, Russian Federation.
Who makes cream 0.1% methylprednisolone aceponate?
cream 0.1% methylprednisolone aceponate is developed and marketed by National Medical Research Center for Children's Health, Russian Federation (see full National Medical Research Center for Children's Health, Russian Federation pipeline at /company/national-medical-research-center-for-children-s-health-russian-federation).
What development phase is cream 0.1% methylprednisolone aceponate in?
cream 0.1% methylprednisolone aceponate is FDA-approved (marketed).